Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/20725
Title: Outcomes of central hepatectomy versus extended hepatectomy.
Authors: Chan, Jenny;Bradshaw, Luke;Houli, Nezor;Weinberg, Laurence;Perini, Marcos V;Fink, Michael A;Muralidharan, Vijayaragavan;Starkey, Graham M;Jones, Robert M;Wang, Bao Zhong;Christophi, Christopher;Nikfarjam, Mehrdad
Affiliation: Department of Surgery, University of Melbourne, Northern Health, Epping, Victoria, Australia
Department of Anaesthesia, Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: 26-Mar-2019
EDate: 2019
Citation: Hepatobiliary & pancreatic diseases international : HBPD INT 2019; online first: 26 March
Abstract: Central hepatectomy (CH) is more difficult than extended hepatectomy (EH) and is associated with greater morbidity. In this modern era of liver management with aims to prevent post-hepatectomy liver failure (PHLF), there is a need to assess outcomes of CH as a parenchyma-sparing procedure for centrally located liver tumors. A total of 178 major liver resections performed by specialist surgeons from two Australian tertiary institutions between June 2009 and March 2017 were reviewed. Eleven patients had CH and 24 had EH over this study period. Indications and perioperative outcomes were compared between the groups. The main indication for performing CH was colorectal liver metastases. There was no perioperative mortality in the CH group and four (16.7%) in the EH group (P = 0.285). No group differences were found in median operative time [CH vs. EH: 450 min (290-840) vs. 523 min (310-860), P = 0.328)], intraoperative blood loss [850 mL (400-1500) vs. 650 mL (100-2000), P = 0.746) or patients requiring intraoperative blood transfusion [(1 (9.1%) vs. 7 (30.4%), P = 0.227)]. There was a trend towards fewer hepatectomy-specific complications in the CH group [3 (27.3%) vs. 13 (54.2%), P = 0.167], including PHLF (CH vs. EH: 0 vs. 29.2%, P = 0.072). Median length of stay was similar between groups [CH vs. EH: 9 days (5-23) vs. 12 days (4-85), P = 0.244]. CH has equivalent postoperative outcomes to EH. There is a trend towards fewer hepatectomy-specific complications, including PHLF. In appropriate patients, CH may be considered as a safe parenchyma-sparing alternative to EH.
URI: http://ahro.austin.org.au/austinjspui/handle/1/20725
DOI: 10.1016/j.hbpd.2019.03.005
ORCID: 0000-0001-7403-7680
0000-0002-0165-1564
0000-0001-8247-8937
0000-0003-4866-276X
PubMed URL: 30987899
ISSN: 1499-3872
Type: Journal Article
Subjects: Central bisectionectomy
Central bisegmentectomy
Central hepatectomy
Extended hepatectomy
Mesohepatectomy
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.